DCP, Sequoia China lead Series B round for medical devices firm Valgen

Greater China-focused private equity firm DCP and tech investment bellwether Sequoia Capital China have co-led a Series B round of financing for Valgen Medtech, a developer of treatment technologies for heart diseases in China. The investment size is said to be “hundreds of millions of US dollars.”